Fusion Pharmaceuticals Inc. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 71 rows in 2024. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2024-06-04: Reporting owner Bitetti Teresa Marie; Form 4; Security Stock Option (Right to Buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2024-06-04: Reporting owner GANNON STEVEN; Form 4; Security Stock Option (Right to Buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2024-06-04: Reporting owner GANNON STEVEN; Form 4; Security Stock Option (Right to Buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2024-06-04: Reporting owner GANNON STEVEN; Form 4; Security Stock Option (Right to Buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2024-06-04 | Bitetti Teresa Marie Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −34,000 0 owned after | $4.16 exercise price | 2024-06-04 | |
| 2024-06-04 | GANNON STEVEN Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −141,011 0 owned after | $2.35 exercise price | 2024-06-04 | |
| 2024-06-04 | GANNON STEVEN Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −30,000 0 owned after | $17.00 exercise price | 2024-06-04 | |
| 2024-06-04 | GANNON STEVEN Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −17,000 0 owned after | $8.15 exercise price | 2024-06-04 | |
| 2024-06-04 | GANNON STEVEN Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −17,000 0 owned after | $3.60 exercise price | 2024-06-04 | |
| 2024-06-04 | GANNON STEVEN Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −17,000 0 owned after | $4.64 exercise price | 2024-06-04 | |
| 2024-06-04 | Valliant John Director, Officer (Chief Executive Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −533,095 0 owned after | $1.02 exercise price | 2024-06-04 | |
| 2024-06-04 | Valliant John Director, Officer (Chief Executive Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −270,300 0 owned after | $1.02 exercise price | 2024-06-04 | |
| 2024-06-04 | Valliant John Director, Officer (Chief Executive Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −606,721 0 owned after | $2.35 exercise price | 2024-06-04 | |
| 2024-06-04 | Valliant John Director, Officer (Chief Executive Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −173,528 0 owned after | $2.99 exercise price | 2024-06-04 | |
| 2024-06-04 | Valliant John Director, Officer (Chief Executive Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −206,541 0 owned after | $17.00 exercise price | 2024-06-04 | |
| 2024-06-04 | Valliant John Director, Officer (Chief Executive Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −372,948 0 owned after | $17.00 exercise price | 2024-06-04 | |
| 2024-06-04 | Valliant John Director, Officer (Chief Executive Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −336,000 0 owned after | $11.90 exercise price | 2024-06-04 | |
| 2024-06-04 | Valliant John Director, Officer (Chief Executive Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −406,600 0 owned after | $7.70 exercise price | 2024-06-04 | |
| 2024-06-04 | Valliant John Director, Officer (Chief Executive Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −500,000 0 owned after | $3.75 exercise price | 2024-06-04 | |
| 2024-06-04 | Valliant John Director, Officer (Chief Executive Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −320,400 0 owned after | $8.44 exercise price | 2024-06-04 | |
| 2024-06-04 | CAGNONI PABLO J Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −30,000 0 owned after | $17.00 exercise price | 2024-06-04 | |
| 2024-06-04 | CAGNONI PABLO J Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −17,000 0 owned after | $8.15 exercise price | 2024-06-04 | |
| 2024-06-04 | CAGNONI PABLO J Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −17,000 0 owned after | $3.60 exercise price | 2024-06-04 | |
| 2024-06-04 | CAGNONI PABLO J Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −17,000 0 owned after | $4.64 exercise price | 2024-06-04 | |
| 2024-06-04 | CAGNONI PABLO J Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −141,011 0 owned after | $2.35 exercise price | 2024-06-04 | |
| 2024-06-04 | Lee Philina Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −30,000 0 owned after | $11.75 exercise price | 2024-06-04 | |
| 2024-06-04 | Lee Philina Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −17,000 0 owned after | $8.15 exercise price | 2024-06-04 | |
| 2024-06-04 | Lee Philina Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −17,000 0 owned after | $3.60 exercise price | 2024-06-04 | |
| 2024-06-04 | Lee Philina Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −17,000 0 owned after | $4.64 exercise price | 2024-06-04 | |
| 2024-06-04 | Rawat Mohit Officer (President & CBO) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −257,000 0 owned after | $8.26 exercise price | 2024-06-04 | |
| 2024-06-04 | Rawat Mohit Officer (President & CBO) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −77,900 0 owned after | $7.70 exercise price | 2024-06-04 | |
| 2024-06-04 | Rawat Mohit Officer (President & CBO) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −300,000 0 owned after | $3.75 exercise price | 2024-06-04 | |
| 2024-06-04 | Rawat Mohit Officer (President & CBO) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −135,500 0 owned after | $8.44 exercise price | 2024-06-04 | |
| 2024-06-04 | Crowley John J Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −38,561 0 owned after | $2.99 exercise price | 2024-06-04 | |
| 2024-06-04 | Crowley John J Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −26,972 0 owned after | $17.00 exercise price | 2024-06-04 | |
| 2024-06-04 | Crowley John J Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −60,852 0 owned after | $17.00 exercise price | 2024-06-04 | |
| 2024-06-04 | Crowley John J Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −138,000 0 owned after | $11.90 exercise price | 2024-06-04 | |
| 2024-06-04 | Crowley John J Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −167,000 0 owned after | $7.70 exercise price | 2024-06-04 | |
| 2024-06-04 | Crowley John J Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −250,000 0 owned after | $3.75 exercise price | 2024-06-04 | |
| 2024-06-04 | Crowley John J Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −106,100 0 owned after | $8.44 exercise price | 2024-06-04 | |
| 2024-06-04 | Crowley John J Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −313,359 0 owned after | $2.19 exercise price | 2024-06-04 | |
| 2024-06-04 | Meek David D. Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −34,000 0 owned after | $4.16 exercise price | 2024-06-04 | |
| 2024-06-04 | Bobilev Dmitri Officer (Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −550,000 0 owned after | $1.98 exercise price | 2024-06-04 | |
| 2024-06-04 | Bobilev Dmitri Officer (Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −151,700 0 owned after | $8.44 exercise price | 2024-06-04 | |
| 2024-06-04 | Bender Jeremy Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −34,000 0 owned after | $4.16 exercise price | 2024-06-04 | |
| 2024-06-04 | Duncan Barbara Gayle Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −30,000 0 owned after | $12.40 exercise price | 2024-06-04 | |
| 2024-06-04 | Duncan Barbara Gayle Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −17,000 0 owned after | $8.15 exercise price | 2024-06-04 | |
| 2024-06-04 | Duncan Barbara Gayle Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −17,000 0 owned after | $3.60 exercise price | 2024-06-04 | |
| 2024-06-04 | Duncan Barbara Gayle Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −17,000 0 owned after | $4.64 exercise price | 2024-06-04 | |
| 2024-06-04 | Burak Eric Officer (Chief Technology Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −159,928 0 owned after | $1.02 exercise price | 2024-06-04 | |
| 2024-06-04 | Burak Eric Officer (Chief Technology Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −81,090 0 owned after | $1.02 exercise price | 2024-06-04 | |
| 2024-06-04 | Burak Eric Officer (Chief Technology Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −72,340 0 owned after | $2.35 exercise price | 2024-06-04 | |
| 2024-06-04 | Burak Eric Officer (Chief Technology Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −38,561 0 owned after | $2.99 exercise price | 2024-06-04 | |
| 2024-06-04 | Burak Eric Officer (Chief Technology Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −44,754 0 owned after | $17.00 exercise price | 2024-06-04 | |
| 2024-06-04 | Burak Eric Officer (Chief Technology Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −69,890 0 owned after | $17.00 exercise price | 2024-06-04 | |
| 2024-06-04 | Burak Eric Officer (Chief Technology Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −139,000 0 owned after | $11.90 exercise price | 2024-06-04 | |
| 2024-06-04 | Burak Eric Officer (Chief Technology Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −41,000 0 owned after | $11.90 exercise price | 2024-06-04 | |
| 2024-06-04 | Burak Eric Officer (Chief Technology Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −45,533 0 owned after | $11.90 exercise price | 2024-06-04 | |
| 2024-06-04 | Burak Eric Officer (Chief Technology Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −45,533 0 owned after | $11.90 exercise price | 2024-06-04 | |
| 2024-06-04 | Burak Eric Officer (Chief Technology Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −168,200 0 owned after | $7.70 exercise price | 2024-06-04 | |
| 2024-06-04 | Burak Eric Officer (Chief Technology Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −250,000 0 owned after | $3.75 exercise price | 2024-06-04 | |
| 2024-06-04 | Burak Eric Officer (Chief Technology Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −106,100 0 owned after | $8.44 exercise price | 2024-06-04 | |
| 2024-06-04 | Leamon Christopher P Officer (Chief Scientific Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −218,000 0 owned after | $7.09 exercise price | 2024-06-04 | |
| 2024-06-04 | Leamon Christopher P Officer (Chief Scientific Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −250,000 0 owned after | $3.75 exercise price | 2024-06-04 | |
| 2024-06-04 | Leamon Christopher P Officer (Chief Scientific Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −106,100 0 owned after | $8.44 exercise price | 2024-06-04 | |
| 2024-06-04 | Bergstrom Donald A Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −34,000 0 owned after | $10.59 exercise price | 2024-06-04 | |
| 2024-06-04 | Bergstrom Donald A Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −17,000 0 owned after | $8.15 exercise price | 2024-06-04 | |
| 2024-06-04 | Bergstrom Donald A Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −17,000 0 owned after | $3.60 exercise price | 2024-06-04 | |
| 2024-06-04 | Bergstrom Donald A Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −17,000 0 owned after | $4.64 exercise price | 2024-06-04 | |
| 2024-01-04 | Leamon Christopher P Officer (Chief Scientific Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +106,100 106,100 owned after | $8.44 exercise price | 2024-01-05 | |
| 2024-01-04 | Crowley John J Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +106,100 106,100 owned after | $8.44 exercise price | 2024-01-05 | |
| 2024-01-04 | Burak Eric Officer (Chief Technology Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +106,100 106,100 owned after | $8.44 exercise price | 2024-01-05 | |
| 2024-01-04 | Rawat Mohit Officer (President & CBO) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +135,500 135,500 owned after | $8.44 exercise price | 2024-01-05 | |
| 2024-01-04 | Bobilev Dmitri Officer (Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +151,700 151,700 owned after | $8.44 exercise price | 2024-01-05 | |
| 2024-01-04 | Valliant John Director, Officer (Chief Executive Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +320,400 320,400 owned after | $8.44 exercise price | 2024-01-05 |